Category: neuroendocrine tumors

Steve Jobs Talks about Liver Transplant

Steve Jobs to Take New Medical Leave from Apple

January 17, 2011

Steve Jobs, CEO and co-founder of Apple and the most well-known member of the carcinoid and neuroendocrine tumor community, is taking a new medical leave of absence.  This announcement was reported today, January 17, 2011, by The New York Times, a year…

READ MORE
CNETS 2010 Conference

Videos from 2010 Vancouver International Carcinoid & NET Cancer Conference Now Online

January 5, 2011

Maureen Coleman, President of CNETS Canada, has announced that videos from the May 2010 international carcinoid and NET cancer conference for patients and medical professionals are now online at http://cnetscanada.org.  According to Ms. Coleman,…

READ MORE
Carolyn Bennett – St. Paul’s

Breaking News from Canada about Carcinoid and Neuroendocrine Cancer Awareness

November 5, 2010

For the first time in the history of Canada’s Federal Parliament, a member of the House of Commons has taken the floor to speak about the need for awareness of neuroendocrine cancer.  On Tuesday, November 2nd, the Honorable, Dr. Carolyn Bennett, PC, MP

READ MORE
Bobby Jindal, Governor of Louisiana

Governors of Louisiana and Montana Join Worldwide NET Cancer Awareness Campaign

October 26, 2010

Governor Bobby Jindal of Louisiana and Governor Brian Schweitzer of Montana have become the 6th and 7th United States governors to pledge their support to the first Worldwide NET Cancer Awareness Day on November 10, 2010Governor Schweitzer wrote,…

READ MORE
NET Cancer Awareness Day Proclamation

Canada’s Dufferin County Council Proclaims Worldwide NET Cancer Awareness Day

October 18, 2010

The Dufferin County Council in Ontario, Canada, has named November 10th as Worldwide NET Cancer Awareness Day.  This is the first municipal proclamation for the Worldwide NET Cancer Awareness Day in Ontario and in Canada. All members of the council signed…

READ MORE
Astor Crown Plaza, New Orleans

2012 National Carcinoid & NETs Conference: Save the Date

September 24, 2010

Dr. Eugene A. Woltering, the Carcinoid Cancer Awareness Network (CCAN), and the New Orleans Neuroendocrine Tumor Specialist team at Ochsner Medical Center – Kenner in Louisiana have announced the dates for the 2012 National Carcinoid/NETs Conference

READ MORE
Ebrahim S. Delpassand, MD, FACNM

FDA Approves Novel Radio-peptide Targeted Therapy Clinical Trial for Neuroendocrine Cancer: PRRT (Peptide Receptor Radionuclide Therapy)

August 24, 2010

For the first time in North America, neuroendocrine cancer patients will have the opportunity to participate in a clinical trial of Lutetieum-177 (LU-177)with Octreotate.   Ebrahim S. Delpassand, MD, chief executive officer and medical director…

READ MORE
MedWatcher

10 More iPhone Apps for Patients and Physicians

August 21, 2010

If you are a carcinoid or neuroendocrine cancer iPhone user, a healthcare provider who treats carcinoid/NETs patients, or a medical student, here are 10 more iPhone apps that will give you information about everything from new drug warnings to places…

READ MORE
Marlena Johnston and partner Gary Hull

Carcinoid Cancer Foundation Welcomes Channeling Jackie-O

August 10, 2010

When Marlena Johnston was first diagnosed with carcinoid cancer of the appendix in April 2010, she went to the Carcinoid Cancer Foundation’s website and embarked on a journey to learn all she could about her rare disease.  She began with Newly Diagnosed:

READ MORE

Fructose vs. Glucose: The Effect of Sugars on Cancer Cells

August 9, 2010

All sugars are not the same when it comes to cancer cells, according to a newly published study by Dr. Anthony Heaney, endocrinologist and neuroendocrine tumor specialist, and his colleagues at UCLA.  The study found that fructose caused pancreatic …

READ MORE